SCHEMBL4860138

SCHEMBL4860138

CCCOB(O)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.40
LMNA P02545 1/20 0.39
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 2/20 0.36
RECQL P46063 1/20 0.36
PCSK9 Q8NBP7 1/20 0.36
HPGD P15428 1/20 0.36
KCNA3 P22001 1/20 0.35
CHRNB2 P17787 2/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA7 P36544 2/20 0.35
CHRNA4 P43681 2/20 0.35
MEN1 O00255 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3729896 0.89 LTA4H (0.50) LTA4HRECQLPCSK9
SCHEMBL4849454 0.87 LTA4H (0.50) LTA4HLMNAALDH1A1PCSK9KCNA3
Boric Acid SCHEMBL28209851 0.87 LTA4H (0.49) LTA4HRECQLPCSK9
SCHEMBL4857508 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL28853194 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL4858379 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL4859393 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL4859499 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL4859270 0.86 LTA4H (0.49) LTA4HLMNAALDH1A1PCSK9
SCHEMBL2126537 0.84 LTA4H (0.41) LTA4HLMNAALDH1A1RECQLPCSK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046889-B2 Polymerizable compound and optically anisotropic body DIC CORPORATION (JP) 2021-06-29 US disclosed
US-20180362847-A1 POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY DIC CORPORATION (JP) 2018-12-20 US disclosed
CN-105026408-B Metallocene compound, olefin polymer catalyst, the manufacturing method of olefin polymer and olefin polymer 日本聚乙烯株式会社 2018-09-11 CN disclosed
US-7410925-B2 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-08-12 US disclosed
US-7008897-B2 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-07 US disclosed
US-20060030480-A1 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2006-02-09 US disclosed
US-20040209763-A1 Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer SUMITOMO CHEMICAL COMPANY, LIMITED 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046889-B2 Polymerizable compound and optically anisotropic body OCIAD1, RCC1, OCIAD2 LTA4H 899/4885LMNA 1251/4885KMT2A 4308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.